RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden
RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden
RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
BIBLIOGRAFÍA<br />
1368. Zucchelli P, Santoro A, Zuccala A. Genesis and control of<br />
hypertension in hemodialysis patients. Semin Nephrol<br />
8:163-168, 1998.<br />
1369. 1368. 1573. Rahman M, Fu P, Sehgal AR, Smith MC.<br />
Interdialytic weight gain, compliance with dialysis regimen,<br />
and age are independent predictors of blood pressure in<br />
hemodialysis patients. Am J Kidney Dis 35:257-265, 2000.<br />
1370. Tomita J, Kimura G, Inoue T, Inenaga T, Sanai T, Kawano Y y<br />
cols. Role of systolic BP in determining prognosis of hemodialyzed<br />
patients. Am J Kidney Dis 25:405-412, 1995.<br />
1371. Tozawa M, Iseki K, Iseki C, Takishita S. Pulse pressure and<br />
risk of total mortality and cardiovascular events in patients<br />
on chronic hemodialysis. Kidney Int 61: 717-726, 2002.<br />
1372. Amar J, Vernier I, Rossignol E, Bongard V, Arnaud C, Conte JJ,<br />
Salvador M, Chamontin B. Nocturnal blood pressure and<br />
24-hour pulse pressure are potent indicators of mortality in<br />
hemodialysis patients. Kidney Int 57: 2485-2491, 2000.<br />
1373. Gunal AI, Duman S, Ozkahya M, Toz H, Asci G, Akcicek F,<br />
Basci A. Treatment of hypertension in dialysis patients by<br />
ultrafiltration: Role of cardiac dilatation and time factor. Am<br />
J Kidney Dis;37:588, 2001.<br />
1374. Lins RL, Elseviers M, Rogiers P, Van Hoeyweghen RJ, De<br />
Raedt H, Zachee P, Daelemans RA. Importance of volume<br />
factors in dialysis related hypertension. Clin Nephrol 48:29-<br />
33, 1997.<br />
1375. Dionisio P, Valenti M, Bergia R, Caramello E, Stramignoni E,<br />
Berto IM, y cols. Influence of the hydration state on blood<br />
pressure values in a group of patients on regular maintenance<br />
hemodialysis. Blood Purif 15:25-33, 1997.<br />
1376. Salem MM. Hypertension in the hemodialysis population: A<br />
survey of 649 patients. Am J Kidney Dis 26:461-468, 1995.<br />
1377. Hörl MP, Hörl WH. Hemodialysis-Associated hypertension:<br />
pathophysiology and therapy. Am J Kidney Dis 39:227-244,<br />
2002.<br />
1378. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F,<br />
Fouad-Tarazi F y cols. Sympathetic overactivity in patients<br />
with chronic renal failure. N Engl J Med 327:1912-<br />
1928,1992.<br />
1379. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei<br />
LT, Boomsma F y cols. Reduction of sympathetic hyperactivity<br />
by enalapril in patients with chronic renal failure. N Engl<br />
J Med 340:1321-1328, 1999.<br />
1380. Grekas D, Kalevrosoglou I, Karamouzis M, Geropoulou E,<br />
Kabouris H, Tourkantonis A. Effect of sympathetic and plasma<br />
renin activity on hemodialysis hypertension. Clin<br />
Nephrol 55:115-120, 2001.<br />
1381. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S y<br />
cols. Plasma endothelin levels in hypertension and chronic<br />
renal failures. Hypertension 15:493, 1990.<br />
1382. Koyama H, Tabata T, Nishizawa Y, Inoue T, Morii H, Yamaji T.<br />
Plasma endothelin levels in patients with uremia. Lancet<br />
1:991, 1989.<br />
1383. Suzuki N, Matsumoto H, Miyauchi T. Endothelin-3 concentrations<br />
in human plasma: The increased concentrations in<br />
patients undergoing hemodialysis. Biochem Biophys Res<br />
Commun 169:809, 1999.<br />
1384. Vallance P, Leone A, Calver A, Collier J, Moncada S.<br />
Accumulation of an endogenous inhibitor of nitric oxide<br />
synthesis in chronic renal failure. Lancet 339:572-575, 1992.<br />
1385. Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M,<br />
Koch KM, y cols. Asymmetric dimethylarginine plasma concentrations<br />
differ in patients with end-stage renal disease:<br />
Relationship to treatment method and atherosclerotic disease.<br />
J Am Soc Nephrol 10:594-600, 1999.<br />
1386. Anderstam B, Katzarski K, Bergström J. Serum levels of NG,<br />
NG-dimethyl-L-arginine, a potential endogenous nitric<br />
oxide inhibitor in dialysis patients. J Am Soc Nephrol<br />
8:1437-1442, 1997.<br />
1387. Morris ST, Jardine AG. The vascular endothelium in chronic<br />
renal failure. J Nephrol 13:96-105, 2000.<br />
1388. Morris STW, McMurray JJV, Rodger RSC, Jardine AG.<br />
Impaired endothelium-dependent vasodilatation in uraemia.<br />
Nephrol Dial Transplant 15:1194-1200, 2000.<br />
1389. Raine AE, Roger SD. Effects of erythropoietin on blood pressure.<br />
Am J Kidney Dis 18 (suppl 1):76-83, 1991.<br />
1390. Buckner FS, Eschbach JW, Haley NR, Davidson RC,<br />
Adamson JW. Hypertension following erythropoietin therapy<br />
in anemic hemodialysis patients. Am J Hypertension 3:947-<br />
955, 1990.<br />
1391. Abraham PA, Macres MG. Blood pressure in hemodialysis<br />
patients during amelioration of anemia with erythropoietin.<br />
J Am Soc Nephrol 2:927-936, 1991.<br />
1392. Canadian Erythropoietin Study Group. Effect of recombinant<br />
human erythropoietin therapy on blood pressure in haemodialysis<br />
patients. Am J Nephrol 11:23-26;1991<br />
1393. Kaupke CJ, Kim S, Vaziri ND. Effect of erythrocyte mass on<br />
arterial blood pressure in dialysis patients receiving maintenance<br />
erythropoietin therapy. J Am Soc Nephrol 4:1874-<br />
1878, 1994.<br />
1394. Torralbo A, Herrerro JA, Portoles J, Fontanellas A, Barrientos<br />
A. Activation of the sympathic nervous system in hemodialysed<br />
patients treated with EPO. Nephron 69:350 (letter),<br />
1995.<br />
1395. Berns JS, Rudnick MR, Cohen RM, Bower JD, Wood BC.<br />
Effects of normal hematocrit on ambulatory blood pressure<br />
in epoetin-treated hemodialysis patients with cardiac disease.<br />
Kidney Int 56:253-260, 1999<br />
1396. Massry SG, Iseki K, Campese VM. Serum calcium, parathyroid<br />
hormone and blood pressure. Am J Nephrol 6:119-128,<br />
1986.<br />
1397. Ifudu O, Matthew JJ, Macey LJ, Hong JS, Sumrani N, Sommer<br />
BG y cols. Parathyroidectomy does not correct hypertension<br />
in patients on maintenance hemodialysis. Am J Nephrol<br />
18:28-34, 1998.<br />
1398. Raine AE, Bedford L, Simpson AW, Ashley CC, Brown R,<br />
Woodhead JS, y cols. Hyperparathyroidism, platelet intracellular<br />
free calcium and hypertension in chronic renal failure.<br />
Kidney Int 43:700-705 , 1993.<br />
1399. Goldsmith DJ, Covic AA, Venning MC, Ackrill. Blood pressure<br />
reduction after patients for secondary hyperparathyroidism:<br />
Further evidence implicating calcium homeostasis in<br />
blood pressure regulation. Am J Kidney Dis 27:819-825,<br />
1996.<br />
1400. Fliser D, Franek E, Fode P, Stefanski A, Schmitt CP, Lyons M<br />
y cols. Subacute infusion of physiological doses of parathyroid<br />
hormone raises blood pressure in humans. Nephrol Dial<br />
Transplant 12:933-938, 1997.<br />
1401. Coomer RW, Schulman G, Breyer JA, Shyr Y. Ambulatory<br />
blood pressure monitoring in dialysis patients and estimation<br />
of mean interdialytic blood pressure. Am J Kidney Dis<br />
29:678-684, 1997.<br />
229